Bradley Foster & Sargent’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$322K Hold
3,272
﹤0.01% 469
2026
Q1
$306K Hold
3,272
﹤0.01% 452
2025
Q4
$319K Hold
3,272
﹤0.01% 453
2025
Q3
$290K Hold
3,272
﹤0.01% 469
2025
Q2
$282K Hold
3,272
﹤0.01% 468
2025
Q1
$298K Sell
3,272
-75
-2% -$6.81K 0.01% 403
2024
Q4
$288K Hold
3,347
﹤0.01% 417
2024
Q3
$329K Sell
3,347
-500
-13% -$48.5K 0.01% 403
2024
Q2
$357K Hold
3,847
0.01% 386
2024
Q1
$358K Hold
3,847
0.01% 379
2023
Q4
$334K Sell
3,847
-254
-6% -$21.1K 0.01% 384
2023
Q3
$349K Hold
4,101
0.01% 376
2023
Q2
$349K Hold
4,101
0.01% 376
2023
Q1
$342K Sell
4,101
-125
-3% -$10.4K 0.01% 364
2022
Q4
$359K Hold
4,226
0.01% 356
2022
Q3
$318K Hold
4,226
0.01% 360
2022
Q2
$343K Hold
4,226
0.01% 363
2022
Q1
$370K Buy
+4,226
New +$358K 0.01% 384

Other funds holding IXJ

Bradley Foster & Sargent's IXJ Position: Q2 2026 in Review

Bradley Foster & Sargent held its iShares Global Healthcare ETF (IXJ) position steady in Q2 2026 at 3,272 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

Bradley Foster & Sargent first reported a position in IXJ in Q1 2022 and has held it in 18 quarters since. The position peaked at $370K in Q1 2022. 301 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.

  • Bradley Foster & Sargent held 3,272 shares of iShares Global Healthcare ETF worth $322K as of Q2 2026.
  • Bradley Foster & Sargent left its iShares Global Healthcare ETF share count unchanged in Q2 2026.
  • iShares Global Healthcare ETF made up ﹤0.01% of Bradley Foster & Sargent's portfolio in Q2 2026, its #469 holding.
  • Bradley Foster & Sargent first reported a position in iShares Global Healthcare ETF in Q1 2022 and has held it in 18 quarters since.
  • Bradley Foster & Sargent's iShares Global Healthcare ETF position peaked at $370K in Q1 2022.
  • 301 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.